Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
EYA3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
HLA-DPA1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CTDSP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PMS2P1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
ACTR3C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
APOLD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IRF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZKSCAN5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC150051 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TBC1D31 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UBE2D4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARMC10 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DPYD - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TERF2IP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KMT2C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SND1-IT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LMNB2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
USP33 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on